Skip to main content
Premium Trial:

Request an Annual Quote

Cynvenio Receives CAP Accreditation

NEW YORK(GenomeWeb) – Cynvenio Biosystems today announced that its laboratory has received accreditation from theCollegeofAmerican Pathologists. 

The Los Angeles-based molecular diagnostics firm said that the US federal government recognizes the CAP accreditation program as being equal to or more stringent than its own inspection program. During the accreditation process, inspectors examine the lab's records and quality control procedures for the preceding two years, as well as staff qualifications, equipment, facilities, safety program and record, and overall management. 

Cynvenio received CLIA certification in 2013. It has developed a technology called LiquidBiopsy that characterizes tumor cells from a standard blood draw. In June it raised $25.5 million in a Series B financing round to advance the clinical development and commercialization of the technology.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.